Ruicheng Wei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ruicheng Wei has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Ran Wang
Jiangsu Academy of Agricultural Sciences
3 shared publications Lei Zhu
Jiangsu Key Laboratory for Food Quality and Safety—State Key Laboratory Cultivation Base of Ministry of Science and Technology, Institute of Food Safety and Nutrition, Jiangsu Academy of Agricultural Sciences, Nanjing, China
2 shared publicationsMinmin Tang
Jiangsu Key Laboratory for Food Quality and Safety—State Key Laboratory Cultivation Base of Ministry of Science and Technology, Institute of Food Safety and Nutrition, Jiangsu Academy of Agricultural Sciences, Nanjing, China
2 shared publicationsFeng Ge
Nanjing Institute of Environmental Science Ministry of Environmental Protection Nanjing 210042 China
1 shared publicationFengting Luan
Jiangsu Key Laboratory for Food Quality and Safety—State Key Laboratory Cultivation Base of Ministry of Science and Technology, Institute of Food Safety and Nutrition, Jiangsu Academy of Agricultural Sciences, Nanjing, China
1 shared publicationHongduo Bao
Institute of Food Safety and Nutrition, Jiangsu Academy of Agricultural Sciences, Nanjing, Jiangsu, China
1 shared publication
Latest Publications
- Open Access
- 19 March 2024
- Published by MDPI AG in Antibiotics
- Vol. 13 (3) , 276
Sub-MIC Antibiotics Modulate Productions of Outer Membrane Vesicles in Tigecycline-Resistant Escherichia coli
Antimicrobial resistance (AMR) has been recognized as one of the most important crises affecting global human health in the 21st century. Tigecycline is one of the last resort antibiotics for treating severe infections caused by multi-drug resistant Enterobacteriaceae. However, the mobile resistance gene tet(X4), which could mediate high-level tigecycline resistance, was discovered in 2019. The outer membrane vesicle (OMV) has been recognized as a new route for horizontal gene transfer; antimicrobial resistant bacteria also have the ability to secret OMVs, while little is known about the impact of antibiotics on the secretion and characteristics of OMVs from tigecycline resistant bacteria till now. This study aimed to investigate the effects of antibiotics on the production and traits of a tigecycline resistant Escherichia coli strain of 47EC. The results showed that sub-inhibitory (1/2 MIC or 1/4 MIC) concentrations of gentamicin, meropenem, ceftazidime, chloramphenicol, tigecycline, ciprofloxacin, polymycin, rifaximin and mitomycin C could significantly increase the secretion of OMVs (0.713 ± 0.05~6.333 ± 0.15 mg/mL) from E. coli 47EC compared to the respective untreated control (0.709 ± 0.03 mg/mL). In addition, the particle sizes of OMVs were generally larger, and the zeta potential were lower in the antibiotics-treated groups than those of the antibiotic-free group. The copy numbers of the tigecycline resistance gene of tet(X4) in the OMVs of most antimicrobial-treated groups were higher than that of the control group. Moreover, transcriptome analysis on ciprofloxacin-treated E. coli 47EC indicated that the SOS response and prophage activation might participate in the ciprofloxacin-induced OMV formation. In conclusion, the clinical application of antibiotics in treating bacterial infections, especially multi-drug resistant bacteria, might lead to the increased secretion of bacterial OMVs and the enrichment of antimicrobial-resistant genes in the OMVs.
- 19 March 2024
- Published by MDPI AG in Antibiotics
- Vol. 13 (3) , 276
Open AccessSub-MIC Antibiotics Modulate Productions of Outer Membrane Vesicles in Tigecycline-Resistant Escherichia coli
Antimicrobial resistance (AMR) has been recognized as one of the most important crises affecting global human health in the 21st century. Tigecycline is one of the last resort antibiotics for treating severe infections caused by multi-drug resistant Enterobacteriaceae. However, the mobile resistance gene tet(X4), which could mediate high-level tigecycline resistance, was discovered in 2019. The outer membrane vesicle (OMV) has been recognized as a new route for horizontal gene transfer; antimicrobial resistant bacteria also have the ability to secret OMVs, while little is known about the impact of antibiotics on the secretion and characteristics of OMVs from tigecycline resistant bacteria till now. This study aimed to investigate the effects of antibiotics on the production and traits of a tigecycline resistant Escherichia coli strain of 47EC. The results showed that sub-inhibitory (1/2 MIC or 1/4 MIC) concentrations of gentamicin, meropenem, ceftazidime, chloramphenicol, tigecycline, ciprofloxacin, polymycin, rifaximin and mitomycin C could significantly increase the secretion of OMVs (0.713 ± 0.05~6.333 ± 0.15 mg/mL) from E. coli 47EC compared to the respective untreated control (0.709 ± 0.03 mg/mL). In addition, the particle sizes of OMVs were generally larger, and the zeta potential were lower in the antibiotics-treated groups than those of the antibiotic-free group. The copy numbers of the tigecycline resistance gene of tet(X4) in the OMVs of most antimicrobial-treated groups were higher than that of the control group. Moreover, transcriptome analysis on ciprofloxacin-treated E. coli 47EC indicated that the SOS response and prophage activation might participate in the ciprofloxacin-induced OMV formation. In conclusion, the clinical application of antibiotics in treating bacterial infections, especially multi-drug resistant bacteria, might lead to the increased secretion of bacterial OMVs and the enrichment of antimicrobial-resistant genes in the OMVs.
- Open Access
- 13 April 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (2) , e0425122
Comprehensive Analysis of Antimicrobial, Heavy Metal, and Pesticide Residues in Commercial Organic Fertilizers and Their Correlation with Tigecycline-Resistant tet (X)-Variant Genes
An antimicrobial resistance gene (ARG) is considered a novel contaminant for the environment. Most animal feces are usually made into commercial organic fertilizers in China and will pose a threat to the farmland soil and agricultural product if fertilizers harboring clinically significant antimicrobial-resistant (AMR) genes are applied on farmland.
- 13 April 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (2) , e0425122
Open AccessComprehensive Analysis of Antimicrobial, Heavy Metal, and Pesticide Residues in Commercial Organic Fertilizers and Their Correlation with Tigecycline-Resistant tet (X)-Variant Genes
An antimicrobial resistance gene (ARG) is considered a novel contaminant for the environment. Most animal feces are usually made into commercial organic fertilizers in China and will pose a threat to the farmland soil and agricultural product if fertilizers harboring clinically significant antimicrobial-resistant (AMR) genes are applied on farmland.
- 1 February 2022
- Published by Elsevier in Food Chemistry
- Vol. 370, 131276
Facile synthesis of Au@Ag core–shell nanorod with bimetallic synergistic effect for SERS detection of thiabendazole in fruit juice
- 1 February 2022
- Published by Elsevier in Food Chemistry
- Vol. 370, 131276
Facile synthesis of Au@Ag core–shell nanorod with bimetallic synergistic effect for SERS detection of thiabendazole in fruit juice
- 1 May 2019
- Published by Elsevier in Chemosphere
- Vol. 222, 722-731
Testosterone disruptor effect and gut microbiome perturbation in mice: Early life exposure to doxycycline
- 1 May 2019
- Published by Elsevier in Chemosphere
- Vol. 222, 722-731
Testosterone disruptor effect and gut microbiome perturbation in mice: Early life exposure to doxycycline
- 1 September 2012
- Published by Wiley in Journal of Environmental Quality
- Vol. 41 (5) , 1481-1486
Occurrence of Ciprofloxacin, Enrofloxacin, and Florfenicol in Animal Wastewater and Water Resources
Antimicrobial agent residues are becoming an intractable environmental problem in soil, surface, and underground water. To obtain a broad profile of residues in animal wastewater and surface water, 24 animal wastewater, 8 animal farm effluent, 18 river water, and 8 pond water samples taken in Jiangsu in eastern China were monitored for enrofloxacin, ciprofloxacin, and florfenicol using solid phase extraction and high performance liquid chromatography/electrospray ionization–tandem mass spectrometry (HPLC/ESI–MS/MS) techniques. The results revealed that two antibacterials were detected simultaneously in 49.1% of samples, followed by three antibacterials (22.6%) and one antibacterial (22.6%). Up to 3.35, 5.93, and 2.10 μg L−1 for ciprofloxacin, 1.09, 4.24, and 0.50 μg L−1 for enrofloxacin, and 0.95, 2.40, and 2.84 μg L−1 for florfenicol were detected in animal farm‐effluent, river, and pond water, respectively. The maximum concentrations of ciprofloxacin and enrofloxacin in animal wastewaters were 7.49 and 8.77 μg L−1, respectively. Furthermore, residue levels of ciprofloxacin and florfenicol showed at least two statistical differences between any two sampling areas or two animal farms. Enrofloxacin showed no statistical difference among the sampling areas and the animal farms.
- 1 September 2012
- Published by Wiley in Journal of Environmental Quality
- Vol. 41 (5) , 1481-1486
Occurrence of Ciprofloxacin, Enrofloxacin, and Florfenicol in Animal Wastewater and Water Resources
Antimicrobial agent residues are becoming an intractable environmental problem in soil, surface, and underground water. To obtain a broad profile of residues in animal wastewater and surface water, 24 animal wastewater, 8 animal farm effluent, 18 river water, and 8 pond water samples taken in Jiangsu in eastern China were monitored for enrofloxacin, ciprofloxacin, and florfenicol using solid phase extraction and high performance liquid chromatography/electrospray ionization–tandem mass spectrometry (HPLC/ESI–MS/MS) techniques. The results revealed that two antibacterials were detected simultaneously in 49.1% of samples, followed by three antibacterials (22.6%) and one antibacterial (22.6%). Up to 3.35, 5.93, and 2.10 μg L−1 for ciprofloxacin, 1.09, 4.24, and 0.50 μg L−1 for enrofloxacin, and 0.95, 2.40, and 2.84 μg L−1 for florfenicol were detected in animal farm‐effluent, river, and pond water, respectively. The maximum concentrations of ciprofloxacin and enrofloxacin in animal wastewaters were 7.49 and 8.77 μg L−1, respectively. Furthermore, residue levels of ciprofloxacin and florfenicol showed at least two statistical differences between any two sampling areas or two animal farms. Enrofloxacin showed no statistical difference among the sampling areas and the animal farms.